ECGI (ECGI) Stock Price & Analysis
ECGI (ECGI) rose 0.00% to USD 0 as of September 8, 2026 at 12:44 UTC, according to Nexqual real-time market data.
ECGI last closed at USD 0; the session ranged USD 0–0 on volume of 6,000,000 shares. Market capitalization is $174,217, with a 52-week range of USD 0–0 (OID). Source: Nexqual, September 8, 2026 at 12:44 UTC.
Key Statistics (as of September 8, 2026 at 12:44 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0 |
| Volume | 6,000,000 shares |
| Market Cap | $174,217 |
| Exchange | OID |
Technical Analysis (ECGI)
Nexqual's technical model rates ECGI "STRONG SELL" based on 0 bullish and 5 bearish signals across 129 daily candles, as of September 8, 2026 at 12:44 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 30.77 (neutral) |
| vs SMA50 | Below (USD 0) |
| MACD | 0 (negative) |
Analyst Ratings (ECGI)
Wall Street analysts rate ECGI "None", per Nexqual as of September 8, 2026 at 12:44 UTC.
| Consensus Rating | None |
|---|
Earnings (ECGI)
Source: Nexqual, September 8, 2026 at 12:44 UTC.
Financials & Fundamentals (ECGI)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| Current Ratio | 0.02 |
| Total Cash | $131,849 |
| Total Debt | $1.82M |
Source: Nexqual, September 8, 2026 at 12:44 UTC.
Financial Health Score (ECGI)
Nexqual rates ECGI's overall financial health "Mixed" across five dimensions, as of September 8, 2026 at 12:44 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Weak — Gross margin 0%, operating 0% |
| Balance Sheet | Mixed — $132K cash vs $2M debt |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Ownership (ECGI)
| Shares Outstanding | 871.09M |
|---|
Source: Nexqual, September 8, 2026 at 12:44 UTC.
Leadership (ECGI)
ECGI is led by Jamie Steigerwald, Chief Executive Officer, per Nexqual as of September 8, 2026 at 12:44 UTC.
| Chief Executive Officer | Jamie Steigerwald |
|---|---|
| Chairman of the Board of Directors & President | William Chung (age 33) |
| Acting CFO & Consultant | Danny Q. Wong (age 35) |
| Chief Technology Officer | Mandeep Singh C.F.A. |
| Vice President of Sales & Marketing | Joseph K. Hashim |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BCON | Beacon Holding Company, Inc. | USD 12.5 | ▲ 0% |
| AAC | Ares Acquisition Corporation II | USD 10.06 | ▼ 0.1% |
| BIOM | Biomolecular Life Holdings, Inc. | USD 0.41 | ▼ 14.55% |
| ESMC | Escalon Medical Corp. | USD 0.17 | ▲ 0% |
| IPIX | Innovation Pharmaceuticals Inc. | USD 0 | ▼ 100% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 12:44 UTC. This page is informational and not investment advice.